Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insuline humaine recombinante |
Is a |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin human antibody measurement |
Has measured component |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin antibody (substance) |
Direct substance |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin human antibody measurement |
Component |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin analog product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Humulin insulin adverse reaction |
Causative agent (attribute) |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to human insulin |
Causative agent (attribute) |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin 100units/mL injection cartridge (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin 100iu/mL injection vial (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100iu/mL injection vial (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100units/mL injection 3mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline lispro 100 unités/mL, stylo prérempli de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insulina aspartat |
Is a |
True |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100units/mL injection 3mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human isophane insulin 100units/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human insulin 100units/mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human isophane insulin 100units/mL prefilled pen (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 25/75 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 50/50 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 10/90 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 20/80 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 20/80 100units/mL injection 3mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 20/80 100units/mL injection 3mL prefilled pen (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 30/70 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 40/60 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 40/60 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 50/50 100u/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 15/85 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 15/85 100units/mL injection 5mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic isophane human 25/75 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 25/75 100units/mL injection 3mL cartridge(product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin soluble human 100units/mL injection 5mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin soluble human 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100u/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100u/mL injection solution 1.5mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin human 30% w/v insulin susp isophane recomb 70% injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin aspart (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human isophane insulin 100units/mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin aspart and insulin aspart protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Semisynthetic human insulin |
Is a |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin zinc crystalline human suspension 100units/mL injection vial (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 30/70 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 50/50 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 10/90 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane human 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 40/60 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin soluble human 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin soluble human 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin soluble human 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin zinc suspension mixed human 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human insulin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|